Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Captopril Nebulization in COVID-19 Pneumonia
NCT04355429Phase 2Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of captopril in COVID-19 pneumonia, sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
captopril
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04355429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04355429.